Menu Reacting - Research and action Inserm - La science pour la santé

REACTing is a multi-disciplinary collaborative network of French research institutions
working on emerging infectious diseases, which aims to prepare and respond to epidemics.

Funding opportunities

CEPI Call for proposal: Human vaccine development against Rift Valley fever and Chikungunya diseases

READ MORE
Publication

Zika virus induces strong inflammatory responses and impairs homeostasis and function of the human retinal pigment epithelium

See article
Video

Ebola : un reportage au cœur de l’essai vaccinal PREVAC

See video
Publication

REACTing: the French response to infectious disease crises

See article
Twitter

Follow us on Twitter and stay up-to-date with REACTing's activities

Follow us
REACTing aims to forge a new dynamic to face health emergency situations by contributing to national health decisions and to international efforts to control emerging infectious threats. Read more
Zika virus

Our Mission

Research prepardness for future epidemics
Integrating research during epidemics
REACTing aims to forge a new dynamic to face health emergency situations by providing research coordination before and during epidemics.

Read more
REACTing is a multi-disciplinary project, coordinated by Inserm under the aegis of Aviesan, the French National Alliance for Life Sciences and Health. It brings together excellent research groups, institutions and laboratories in order to prepare and deal with unforeseeable emerging infectious threats.
aviesan - alliance nationale pour les sciences de la vie et de la sante

Our Activities

2018 - August
Ebola (Democratic Republic of Congo)
2018 - May
Ebola (Democratic Republic of Congo) Learn more
2018
Lassa (Nigeria) Learn more
2017
Plague (Madagascar)
2017
Marburg (Uganda)
2017
Ebola (Democratic Republic of Congo)
2017
Lassa (Togo)
2015
Zika (French West Indies, South America, France)
2014
Ebola (West Africa)
2013
Chikungunya (French West Indies)
Read more